On April 17, 1957, Maurice Hilleman opened his morning newspaper and read a short item about an influenza outbreak in Hong Kong.
The article ran about eight sentences. It described crowded clinics and children carried in with a glassy-eyed stare, a symptom that stood out to a man who had spent his career studying flu viruses.
Hilleman worked as a virologist at the Walter Reed Army Medical Research Institute. Reports later put the number of Hong Kong residents seeking treatment at close to 250,000, roughly ten percent of the region's population.
He did not wait for a government agency to raise the alarm.
Within about a month, Hilleman had requested a sample of the virus from colleagues in Asia and tested it against blood from Americans. The results showed almost no existing immunity in the United States population to this strain.
He concluded a pandemic was likely to reach the country by the fall.
$8B is moving in... are you?
So here's a number that got my attention.
Venture capital investment in U.S. crypto companies hit $7.9 billion last year.
Up 44% from the year before.
These are the smartest, most ruthless investors on earth.
And they're betting nearly $8 billion on blockchain.
This isn't some meme coin or flash in the pan crypto trend.
This is infrastructure.
Payment rails, settlement systems.
The digital plumbing that moves our money faster, cheaper, and safer.
The exact same thing that President Trump plans to force $382 trillion worth of financial assets onto by April of 2027.
And there's a single digital asset sitting at the center of everyone of these transactions.
It's the one token that every institution must hold to operate on this new system
That's why BlackRock, JPMorgan, Fidelity are already accumulating this fuel now (while it's on sale).
But I don't suggest waiting until the rest of Wallstreet catches on.
By then the big gains are out the window and you could be left fighting for scraps with everyone else.
Hilleman issued public statements laying out the timeline and pushed vaccine manufacturers to begin production immediately, ahead of the usual review process. He told them the country would need an enormous supply of fertilized chicken eggs, since eggs were how flu vaccines were grown at the time.
He passed word to farmers directly. Do not cull your roosters at the end of the season. The vaccine effort would need them.
He worked around some of the normal regulatory steps to keep the timeline from slipping.
By September 1957, when the virus arrived in the United States in force, roughly 40 million doses of vaccine were already distributed. The 1957 pandemic still killed an estimated 116,000 Americans and over a million people worldwide.
Public health historians have since credited Hilleman's early call with meaningfully reducing what that toll would otherwise have been, given how little advance warning most pandemics allow.
Hilleman spent the rest of his career at Merck, where he developed more than 40 vaccines, including eight of the fourteen shots still routinely given to American children today, among them measles, mumps, hepatitis A, and hepatitis B.
Public health researchers, including physicians at the Children's Hospital of Philadelphia, have estimated his vaccines save close to eight million lives a year around the world. His measles vaccine alone is credited with preventing roughly a million deaths.
Hilleman died in 2005. Most people outside his field have never heard his name.
He did not have proof of a pandemic in April 1957. He had eight sentences in a newspaper, a symptom he recognized, and a decision to move before he could be certain he was right.
If you read eight sentences everyone else skipped past, would you have moved as fast as he did while it was still just a hunch?